Viewing Study NCT00487435

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:08 PM
Ignite Modification Date: 2026-02-22 @ 3:57 PM
Study NCT ID: NCT00487435
Status: COMPLETED
Last Update Posted: 2014-05-09
First Post: 2007-06-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
None Osteoarthritis View
None Low Back Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CG5503 View
None Tapentadol View
None chronic non-malignant pain View
None osteoarthritis View
None lower back pain View
None analgesic View
None opioid View